Chris Pendleton

Chris Pendleton is an accomplished professional in drug safety and pharmacovigilance with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Drug Safety at BridgeBio since December 2023, Chris has previously held significant roles at Perspective Pharmacovigilance, Inc. as a Senior PV Consultant and PV Consultant, and at PRA Health Sciences, where responsibilities included project management and drug safety. Chris's career also includes experience at Covance as a Senior Drug Safety Associate and Drug Safety Associate, as well as a substantial research background at Vanderbilt University, focusing on drug resistance in triple-negative breast cancer. Chris holds a Master’s Degree in Biochemistry from Vanderbilt University and a Bachelor’s Degree in Recombinant Genetics from Western Kentucky University.